Key statistics
On Wednesday, Edwards Lifesciences Corp (EW:NYQ) closed at 85.22, -3.04% below its 52-week high of 87.89, set on Dec 05, 2025.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
| Open | 85.14 |
|---|---|
| High | 85.81 |
| Low | 84.22 |
| Bid | 84.00 |
| Offer | 87.32 |
| Previous close | 85.28 |
| Average volume | 4.52m |
|---|---|
| Shares outstanding | 580.80m |
| Free float | 572.50m |
| P/E (TTM) | 47.21 |
| Market cap | 49.53bn USD |
| EPS (TTM) | 1.81 USD |
Data delayed at least 15 minutes, as of Mar 04 2026 21:00 GMT.
More ▼
- Edwards Lifesciences Advances Structural Heart Care Through Innovation and Purpose
- Edwards Lifesciences to Present at the Barclays and Leerink Partners Global Healthcare Conferences
- Edwards Lifesciences to Present at Citi’s 2026 Unplugged Medtech and Life Sciences Access Day
- Edwards Lifesciences Reports Fourth Quarter Results
- Edwards Lifesciences to Host Earnings Conference Call on February 10, 2026
- Edwards Lifesciences to Present at the TD Cowen 46th Annual Health Care Conference
- Edwards Comments on JenaValve Acquisition
- FDA Approves Edwards Lifesciences' SAPIEN M3 Mitral Valve Replacement System as First Transseptal Transcatheter Therapy
- Edwards Lifesciences to Present at the 44th Annual J.P. Morgan Healthcare Conference
More ▼
